Skip to content
Marty Makary’s Turbulent Tenure at FDA Comes to an End
Grayson Logue /

Marty Makary’s Turbulent Tenure at FDA Comes to an End

Brought in as an agency critic, the commissioner drew fire from drug developers and abortion foes.
A middle-aged man in a dark suit and red tie looks directly at the camera with a serious expression against a light neutral background.
Food and Drug Administration Commissioner Marty Makary attends an executive order signing regarding psychedelics in the Oval Office of the White House in Washington, D.C., on April 18, 2026. (Photo by Allison Robbert/For The Washington Post via Getty Images)

The writing wasn’t on the wall for Marty Makary—it was in the Wall Street Journal. The Food and Drug Administration (FDA) commissioner resigned Tuesday, just four days after the newspaper reported that President Donald Trump had signed off on Makary’s firing. 

“I’ve been reading about it, but I know nothing about it,” Trump said Friday when asked about plans to fire the commissioner.

Want to see more of The Dispatch in Google search?

Add Us as a Preferred Source

Grayson Logue is a staff writer for The Dispatch and is based in Philadelphia, Pennsylvania. Prior to joining the company in 2023, he worked in political risk consulting, helping advise Fortune 50 companies. He was also an assistant editor at Providence Magazine and is a graduate student at the University of Edinburgh, pursuing a Master’s degree in history. When Grayson is not writing pieces for the website, he is probably working hard to reduce the number of balls he loses on the golf course.

More We Think You’d Like

Loading